02648nam 22006491 450 991097528480332120240314024901.09781608057474160805747X(CKB)2670000000402537(EBL)1336319(OCoLC)855504888(SSID)ssj0001127419(PQKBManifestationID)11669035(PQKBTitleCode)TC0001127419(PQKBWorkID)11150175(PQKB)10182177(MiAaPQ)EBC1336319(Au-PeEL)EBL1336319(CaPaEBR)ebr10762668(DE-B1597)731952(DE-B1597)9781608057474(EXLCZ)99267000000040253720130810d2013 uy 0engur|n|---|||||txtccrErythropoietic stimulating agents /editor, Elisio Costa; co-editors, Flavio Reis and Alice Santos-Silva1st ed.Oak Park, Illinois :Bentham Science Publishers,2013.1 online resource (306 p.)Frontiers in Drug Discovery ;1Frontiers in drug discovery ;v. 1Includes index.9781608057481 1608057488 Cover; TItle; EUL; Contents; Foreword; Preface; List of Contributors; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Chapter 06; Chatper 07; Chapter 08; Chatper 09; Chapter 10; Chapter 11; Chapter 12; Chapter 13; Chapter 14; Index; Bak CoverThis volume includes a revision of articles on erythropoiesis and EPO gene regulation, microRNAs and their potential contribution to the development of new therapeutic strategies, animal models for studying kidney disease-associated anemia as well as benefits/risks of ESA therapy. The biological effects of new ESA molecules, heparin-binding erythropoietin and of pHBSP, and the potential applications of ESA, are also elicited in this volume.Frontiers in Drug DiscoveryErythrocytesErythropoiesisRegulationErythrocytes.ErythropoiesisRegulation.612.111Reis Elísio Costa Flávio, authttp://id.loc.gov/vocabulary/relators/aut1800836Costa Elisio1800837Reis Flávio1800838Santos-Silva Alice1800839MiAaPQMiAaPQMiAaPQBOOK9910975284803321Erythropoietic stimulating agents4345786UNINA